News Pulmocide raises $30m for inhaled anti-infectives A UK biotech company has raised $30 million to fund development of its treatments for respiratory infections.
News Clinical trial go-between Inato raises $20m Inato has raised $20 million in early-stage financing to support the continued development of its clinical trial marketplace, which connects sponsors with its network of t
R&D Sponsored Trials and tribulations of drug development What does it take to establish new treatments for rare diseases?
